By Counterforce Health Team in Eylea / Lucentis (aflibercept / ranibizumab) —

How to Get Eylea or Lucentis Covered by Cigna in California: Complete Guide to Prior Authorization and Appeals

Quick Answer: Getting Eylea/Lucentis Covered by Cigna in California

Your fastest path to approval: Submit prior authorization through CoverMyMeds or call Cigna at 1-800-882-4462 with complete clinical documentation. Include your diagnosis (wet AMD, diabetic macular edema), OCT/FFA imaging, prior treatments tried, and visual acuity measurements. If denied, you have 180 days for internal appeal, then California's Independent Medical Review (IMR) within 30 days. Under California law, urgent requests must be processed within 72 hours.

Start today: Contact your prescribing physician to initiate the prior authorization with all required clinical documentation.

Table of Contents

Why California State Rules Matter

California's robust insurance regulations give you significant advantages when seeking coverage for Eylea (aflibercept) or Lucentis (ranibizumab). Unlike many states, California has two insurance regulators: the Department of Managed Health Care (DMHC) oversees HMOs and most PPOs, while the California Department of Insurance (CDI) regulates other health policies.

These agencies enforce strict timelines for prior authorization decisions and provide powerful appeal rights through Independent Medical Review (IMR). California also has specific protections for step therapy overrides and continuity of care during plan transitions.

Key advantage: If your Cigna plan is DMHC-regulated (most commercial plans), you get binding external review through IMR with no cost to you. The state pays for independent physician experts to review your case.

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for both Eylea and Lucentis Cigna formulary or provider portal Cigna PA Forms
Formulary Tier Varies by plan; typically specialty tier Member portal or plan documents Express Scripts FAQ
Step Therapy May require bevacizumab trial first Plan-specific; check formulary California Step Therapy Law
Diagnosis Codes Wet AMD, DME, DR, RVO with ICD-10 FDA labeling and clinical guidelines Express Scripts Coverage Reviews
Quantity Limits Monthly injection limits may apply Plan formulary documents Cigna Medicare Formulary

Step-by-Step: Fastest Path to Approval

1. Gather Required Documentation

Who: Your retinal specialist's office
What: Complete clinical records including:

  • OCT scans showing macular edema or fluid
  • Fluorescein angiography (if available)
  • Visual acuity measurements
  • Prior treatment history (including bevacizumab trials)
  • Current diagnosis with ICD-10 codes

2. Submit Prior Authorization

Who: Prescribing physician
How: CoverMyMeds portal, SureScripts, or fax to Cigna
Timeline: Submit with complete documentation to avoid delays
Source: Cigna Precertification Guidelines

3. Request Expedited Review (If Urgent)

When: Risk of vision loss or deterioration
Timeline: 72 hours for urgent requests under California law
How: Mark request as "urgent" and provide clinical justification
Source: DMHC Access Standards

4. Follow Up Within 5 Days

Who: Patient or clinic staff
What: Check status via Cigna member portal or call 1-800-882-4462
Why: Standard PA decisions due within 5 business days

5. If Denied, File Internal Appeal Immediately

Timeline: 180 days from denial letter
Required: Denial letter, medical records, physician statement
Source: Cigna member services or provider portal

6. Request Independent Medical Review (IMR)

When: After internal appeal denial or 30-day delay
Timeline: Within 30 days of internal appeal decision
How: DMHC Help Center at 1-888-466-2219
Cost: Free to you

Turnaround Standards and Timelines

California law sets strict deadlines for prior authorization decisions:

Request Type Decision Deadline Source
Urgent/Expedited 72 hours DMHC Regulations
Urgent-Concurrent 24 hours (if submitted ≥24h before current auth expires) California Health & Safety Code §1367.01
Routine 5 business days CHBRP Prior Authorization Analysis
Tip: If Cigna doesn't respond within these timeframes, your request may be automatically approved. Document all submission dates and follow up promptly.

Step Therapy Protections in California

Under AB 347 (2021), California requires health plans to grant step therapy exceptions when:

  • You've already tried and failed the required step therapy drug
  • You experienced significant adverse effects from the required drug
  • The step therapy drug is expected to be ineffective based on your medical history
  • You're currently stable on your current therapy

Timeline for step therapy override decisions:

  • Urgent requests: 24 hours
  • Non-urgent requests: 72 hours

If the plan doesn't respond within these timeframes, your request is automatically approved.

Source: California Chronic Care Coalition

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn Required Documentation
"Not medically necessary" Submit peer-reviewed studies supporting anti-VEGF therapy OCT scans, visual acuity, treatment response data
"Step therapy required" Document bevacizumab failure/intolerance Prior treatment records, adverse event documentation
"Quantity limits exceeded" Provide clinical justification for frequency Injection logs, response monitoring, physician attestation
"Non-formulary drug" Request formulary exception Comparative effectiveness data, clinical rationale
"Insufficient documentation" Resubmit with complete clinical file All imaging, labs, prior treatments, current status

Appeals Playbook for Cigna in California

Internal Appeals (First Level)

Timeline: 180 days from denial letter
How to file:

  • Online: Cigna member portal
  • Phone: 1-800-882-4462
  • Mail: Address on denial letter

Required documents:

  • Original denial letter
  • Complete medical records
  • Physician statement of medical necessity
  • Supporting literature/guidelines

Internal Appeals (Second Level)

Timeline: 60 days from first-level denial
Process: Automatic review by different clinical reviewer
Timeline for decision: 30 days (15 days for urgent)

Independent Medical Review (IMR)

When eligible: After internal appeals exhausted or 30-day delay
Timeline to file: 30 days from internal appeal decision
How to file: DMHC online application or call 1-888-466-2219
Decision timeline: 45 days (7 days for urgent)
Success rate: Approximately 12.7% of denials overturned (2024 data)

Source: California IMR Annual Report

Continuity of Care Protections

If you're currently receiving Eylea or Lucentis and face a plan change or formulary update, California law provides continuity of care protections for up to 12 months.

Eligibility requirements:

  • Pre-existing relationship with your retinal specialist
  • Ongoing course of treatment
  • Provider agrees to continue care

How to request:

  1. Contact your new plan immediately upon notification of change
  2. Provide documentation of current treatment and provider relationship
  3. Submit request within 30 days of plan notification

Processing timelines:

  • Standard requests: 30 days
  • Urgent medical needs: 15 days
  • Risk of harm: 3 days

Source: DMHC Continuity of Care

Scripts and Templates

Patient Phone Script for Cigna

"Hi, I'm calling to check on the status of my prior authorization request for [Eylea/Lucentis]. My member ID is [number] and the request was submitted on [date]. My doctor says this injection is urgent because I'm at risk of vision loss. Can you tell me the status and when I can expect a decision? If it's been more than 72 hours for an urgent request, I'd like to speak with a supervisor about the delay."

Clinic Staff Script for Peer-to-Peer Review

"I'm requesting a peer-to-peer review for [patient name] who needs [Eylea/Lucentis] for [wet AMD/diabetic macular edema]. The treating physician is Dr. [name], a board-certified retinal specialist. We have complete documentation including OCT imaging showing [specific findings] and prior treatment history. When can we schedule the peer-to-peer discussion?"

When to Escalate to State Regulators

Contact the DMHC Help Center at 1-888-466-2219 if:

  • Cigna misses California timeline requirements
  • Your IMR request is improperly denied
  • You need help filing a complaint or IMR application

The DMHC can intervene directly with health plans that violate state regulations and provides free assistance with the appeals process.

Online complaint portal: DMHC File a Complaint

Counterforce Health: Streamlining Your Appeal Process

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. The platform analyzes your denial letter, plan policy, and clinical notes to identify the specific denial basis and draft point-by-point rebuttals aligned to your plan's own rules. For anti-VEGF therapies like Eylea and Lucentis, Counterforce Health pulls the right citations from FDA labeling, peer-reviewed studies, and specialty guidelines, weaving them into appeals with all required clinical facts and operational details payers expect.

FAQ

Q: How long does Cigna prior authorization take in California?
A: Standard requests: 5 business days. Urgent requests: 72 hours under California law. If Cigna misses these deadlines, contact the DMHC Help Center.

Q: What if Eylea or Lucentis is non-formulary on my Cigna plan?
A: You can request a formulary exception with clinical justification. If denied, appeal through internal review then IMR.

Q: Can I request an expedited appeal in California?
A: Yes, for urgent medical situations. Mark your appeal as urgent and provide clinical documentation of the risk to your vision.

Q: Does step therapy apply if I've tried bevacizumab outside California?
A: Yes, document your previous trial and response. California's step therapy override protections apply regardless of where you received prior treatment.

Q: What's the success rate for IMR appeals?
A: About 12.7% of denials are overturned through IMR (2024 data). Success is higher with complete documentation and strong clinical evidence.

Q: Are there costs for filing appeals in California?
A: No. Internal appeals with Cigna are free, and California pays for IMR. There are no fees to patients for the appeals process.

Q: How do I get help with my appeal?
A: Contact the DMHC Help Center (1-888-466-2219), consult with Counterforce Health for appeal strategy, or reach out to California consumer assistance organizations.

Q: What if my doctor isn't familiar with Cigna's requirements?
A: Share this guide with your physician's office. They can also contact Cigna provider services or use platforms like CoverMyMeds for PA requirements and status updates.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider about your specific medical needs and with qualified professionals about insurance matters. Coverage decisions vary by individual plan and clinical circumstances.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.